MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0073990
Shell Lifesciences Private Limited - chemicals and materials in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹24.57 Cr
▼ 26% YoY
Net profit · FY 2024
₹17 Lakh
Net margin 0.7%
EBITDA · FY 2024
₹1.43 Cr
EBITDA margin 5.8%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹60.8 Lakh
Issued & subscribed
Open charges
₹16.99 Cr
Secured borrowings
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings
About Shell Lifesciences Private Limited
Data last updated:
Shell Lifesciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 10 September 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51496MH2007PTC173957. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹60.8 Lakh. It is led by directors Kiran Chandrakant Thakkar and Rajkumar Bahorilal Jaiswal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Unit No. 1413/1414 14th Floor Ghanshyam Enclave Linking Road Kandivali (West), Mumbai, Maharashtra, India – 400067.
As per the financials filed for FY 2024, the company reported a revenue of ₹24.57 Cr, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹17 Lakh (net margin 0.7%) and EBITDA of ₹1.43 Cr (EBITDA margin 5.8%). Revenue has declined at a compounded annual rate (CAGR) of 28% over three years and 14% over five years.
The company is associated with 1 brand: Shell Lifesciences. As per MCA filings, the company has open charges of ₹16.99 Cr on record. Court records list 10 cases involving the company, including 4 filed by the company and 5 filed against it; 3 cases are pending. The company has 9 deals on record (5 secondary share transfers, 4 funding rounds), with disclosed funding of ₹2 Cr; the latest was in March 2023. Its 10 peer companies in the Chemicals industry (Chemical Retail and Distribution, Lifesciences, Pharma Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is Gal Care Pharmaceuticals Private Limited with revenue of ₹24.69 Cr.
Shell Lifesciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0073990). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shelllifesciences.com.
Company Details of Shell Lifesciences Private Limited
CIN U51496MH2007PTC173957
Registration Number 173957
Incorporation Date 10 September 2007
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0073990
Recognitions & Rankings of Shell Lifesciences
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressUnit No. 1413/1414 14th Floor Ghanshyam Enclave Linking Road Kandivali (West), Mumbai, Maharashtra, India – 400067
- IndustryChemicals and Materials, Chemical Distribution & Retail
Comprehensive company report
Shell Lifesciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Shell Lifesciences Private Limited
Shell Lifesciences operates one associated brand: Shell Lifesciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Shell Lifesciences is an R&D company manufacturing drugs for various therapeutic areas. | shelllifesciences.com |
Business Activity of Shell Lifesciences Private Limited
The main business activity of Shell Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Shell Lifesciences Private Limited FY 2024 filings available
Shell Lifesciences Private Limited reported revenue of ₹24.57 Cr (down 26% YoY) for FY 2024.
Revenue · FY 2024
₹24.57 Cr ▼ 26%
Net profit · FY 2024
₹17 Lakh margin 0.7%
EBITDA · FY 2024
₹1.43 Cr margin 5.8%
Compounded Annual Growth Rate (CAGR) of Shell Lifesciences Private Limited
Revenue CAGR growth
1 year
▼ 26%
3 years · compounded
▼ 28%
5 years · compounded
▼ 14%
EBITDA CAGR growth
1 year
▼ 11%
3 years · compounded
▼ 13%
5 years · compounded
▼ 8%
Revenue has declined at a compounded annual rate (CAGR) of 14% over five years, including a 26% fall in the latest year. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Shell Lifesciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.43 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹17 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Shell Lifesciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Shell Lifesciences are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Shell Lifesciences Private Limited
Shell Lifesciences has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajkumar Bahorilal Jaiswal | Additional Director | 10 Jul 2024 | 2 Years 3 Months | Current |
| Kiran Chandrakant Thakkar | Director | 01 Sep 2009 | 17 Years 1 Months | Current |
Peer Comparison of Shell Lifesciences Private Limited
Shell Lifesciences Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Lifesciences, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gal Care Pharmaceuticals Private Limited | ₹24.69 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Jaipur, Rajasthan, India |
| Roma Organics Private Limited | ₹24.67 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Navi Mumbai, Maharashtra, India |
| Bankura Jyotirmoyee Pharma Private Limited | ₹24.63 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | West Bengal, India |
| Hari Medi Pharma Private Limited | ₹24.62 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Sri Ganganagar, Rajasthan, India |
| Nufarm Agriscience Private Limited | ₹24.58 Cr (FY 2015) | •••• | •••• | -63.0% | •••• | Mumbai, Maharashtra, India |
| Shell Lifesciences Private Limited this company | ₹24.57 Cr (FY 2024) | •••• | •••• | -26.0% | •••• | Mumbai, Maharashtra, India |
| Vedant Tradelink Private Limited | ₹24.55 Cr (FY 2024) | •••• | •••• | 29.0% | •••• | Ahmedabad, Gujarat, India |
| Siskaa Chemicals Limited | ₹24.55 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Ahmedabad, Gujarat, India |
| Shanker Global Private Limited | ₹24.49 Cr (FY 2016) | •••• | •••• | 130.0% | •••• | Ahmedabad, Gujarat, India |
| Chandramouli Oil and Engineering Private Limited | ₹24.47 Cr (FY 2025) | •••• | •••• | 839.0% | •••• | Bangalore, Karnataka, India |
| Plasoron Biotech Private Limited | ₹24.46 Cr (FY 2024) | •••• | •••• | 38.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Shell Lifesciences by revenue in the Chemicals industry (Chemical Retail and Distribution, Lifesciences, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Shell Lifesciences Private Limited
Shell Lifesciences Private Limited is audited by SSSS & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SSSS & Associates | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Shell Lifesciences Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Shell Lifesciences Private Limited
Open charges
₹16.99 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jul 2020 | Others | ₹2.02 Cr | Open |
| 31 Jan 2018 | Others | ₹75 Lakh | Open |
| 21 Dec 2017 | Others | ₹55 Lakh | Open |
| 20 Jan 2012 | Others | ₹13.67 Cr | Open |
Total charge records: 4 View all charges
Deals & Funding of Shell Lifesciences Private Limited
Shell Lifesciences Private Limited has 9 deals on record (5 secondary share transfers, 4 funding rounds), with disclosed funding of ₹2 Cr; the latest was in March 2023.
Total deals
9
Secondary share transfers
5
Funding rounds
4
Disclosed funding
₹2 Cr
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2016 | Funding round | ₹55 Lakh | Investors: 2 individuals |
| Nov 2014 | Funding round | ₹1.06 Cr | Investors: 3 individuals |
Premium access
Full deal history
All 9 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Shell Lifesciences Private Limited
Shell Lifesciences Private Limited has 10 court cases on record: 4 filed by Shell Lifesciences, 5 filed against it, 1 where it is another party. 3 cases are pending and 7 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Total cases
10
Filed by the company
4
Filed against the company
5
Pending
3
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 2 | 1 |
| District courts | 3 | 2 | 2 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, SURAT, Gujarat | Criminal complaint | Filed against the company by Globela Industries Private Limited | Pending |
| Bombay High Court | Court case (APP) | Filed against the company by Aglowmed Limited | Disposed |
| Bombay High Court | Court case (NMA) | Filed against the company by Aglowmed Limited | Disposed |
| Bombay High Court | Court case (SJ) | Filed by the company against Aglowmed Limited | Disposed |
| Bombay High Court | Court case (SS) | Filed by the company against Aglowmed Limited | Disposed |
Premium access
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Shell Lifesciences Private Limited
Employment history and EPFO contributions of people linked to Shell Lifesciences.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Shell Lifesciences Private Limited
Shell Lifesciences Private Limited has 7 board changes on record since 2009: 2 appointments and 5 cessations. The latest: Rajkumar Bahorilal Jaiswal was appointed as Additional Director on 10 Jul 2024.
AGM
Shell Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Appointed
Rajkumar Bahorilal Jaiswal was appointed as Additional Director.
Ceased
Chandrakant Nagjibhai Thakker ceased to be Director Appointed In Casual Vacancy.
Filing
Shell Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai I.
Ceased
Madhuben Chandrakant Thakker ceased to be Director.
Charges
A charge with Others of Rs. 1,366.95 Lakh registered on 20 Jan 2012 with Charge ID 10336792 was modified on 18 May 2022.
Charges
A charge with Others of Rs. 201.95 Lakh registered on 22 Jul 2020 with Charge ID 100365312 was modified on 18 Feb 2022.
Ceased
Kamlesh Anantrai Mehta ceased to be Director.
Charges
A charge with Others amounted to Rs. 201.95 Lakh with Charge ID 100365312 was registered on 22 Jul 2020.
Charges
A charge with Others amounted to Rs. 75.00 Lakh with Charge ID 100153024 was registered on 31 Jan 2018.
Charges
A charge with Others amounted to Rs. 55.00 Lakh with Charge ID 100143519 was registered on 21 Dec 2017.
Charges
A charge with Others amounted to Rs. 1,366.95 Lakh with Charge ID 10336792 was registered on 20 Jan 2012.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Shell Lifesciences Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Shell Lifesciences Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Shell Lifesciences Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Shell Lifesciences Private Limited
Shell Lifesciences has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Shell Lifesciences Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shell Lifesciences Private Limited
Shell Lifesciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 10 September 2007 (19+ years old) and is registered under CIN U51496MH2007PTC173957.
Shell Lifesciences reported revenue of ₹24.57 Cr for FY 2024 (down 26% YoY).
Shell Lifesciences has 2 current directors:
- Rajkumar Bahorilal Jaiswal - Additional Director
- Kiran Chandrakant Thakkar - Director
Shell Lifesciences reported a net profit of ₹17 Lakh (net margin 0.7%) and EBITDA of ₹1.43 Cr (EBITDA margin 5.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Shell Lifesciences is -28% over three years and -14% over five years. In the latest year (FY 2024) revenue fell 26%. CAGR is the steady yearly rate that links the first and the last year.
No. Shell Lifesciences has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Shell Lifesciences is U51496MH2007PTC173957. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shell Lifesciences has 10 court cases on record: 4 filed by the company and 5 filed against it. 3 are pending. Most are in the high courts.
Shell Lifesciences was incorporated on 10 September 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
Shell Lifesciences has 9 deals on record (5 secondary share transfers, 4 funding rounds), with disclosed funding of ₹2 Cr; the latest was in March 2023.
The peers of Shell Lifesciences by revenue are Gal Care Pharmaceuticals Private Limited, Roma Organics Private Limited, Bankura Jyotirmoyee Pharma Private Limited, Hari Medi Pharma Private Limited, Nufarm Agriscience Private Limited and 5 more, all in the Chemicals industry (Chemical Retail and Distribution, Lifesciences, Pharma Retail and Distribution).